(CYTK:Consolidated Issue listed on NASDAQ Capital Market)
Earnings & Estimates Summary - CYTOKINETICS INC (CYTK)
2013 revenues at Cytokinetics, Incorporated totaled $30.6M USD, while annual losses equaled $1.24 per share.
Quarterly Earnings & Estimates - CYTOKINETICS INC (CYTK)
Cytokinetics, Incorporated's Quarterly Earnings
Cytokinetics, Incorporated reported 2nd quarter 2014 on 08/1/2014.
Annual Earnings & Estimates - CYTOKINETICS INC (CYTK)
Cytokinetics, Incorporated's Annual Earnings
Cytokinetics, Incorporated reported annual 2013 losses of $1.24 per share on 02/8/2014.
Quarterly Revenues - CYTOKINETICS INC (CYTK)
Annual Revenues - CYTOKINETICS INC (CYTK)
Cytokinetics, Incorporated's Annual Revenues
Cytokinetics, Incorporated had revenues for the full year 2013 of $30.6M USD. This was 305.5% above the prior year's results.
|ArQule Inc||$1.88 USD||-0.09|
|CTI BioPharma Corp||$2.34 USD||-0.04|
|Curis Inc||$3.08 USD||-0.07|
|Evotec AG||€3.83 EUR||-0.003|
|Exelixis Inc||$2.93 USD||0.00|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|